Lexpos News

Community Pharmacy England has today released a national report highlighting how pharmacy owners across England are dipping into personal savings to support their businesses, effectively subsidising the provision of NHS services. The Pharmacy Pressures Survey 2025: Funding and Profitability Report sets out once again the desperate financial position community pharmacies are in as a result of [...]

The post Pharmacy owners subsidising NHS services, Pressures Survey shows appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following product: Repaglinide 500microgram,1mg and 2mg tablets MSN/2025/050 Tier 2 – medium impact Date of issue: 26/08/2025 Repaglinide 500microgram and 1mg tablets will be out of stock from late August until early December 2025 Repaglinide 2mg tablets are in [...]

The post Medicine Supply Notification: Repaglinide 500microgram,1mg and 2mg tablets appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Notification: Various Products (Ipca Laboratories UK Limited) Date issued: 26 August 2025 Ipca Laboratories UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the products listed in this notification do not contain all the required safety information. DMRC reference number: DMRC-35766519 Marketing Authorisation Holder: Ipca Laboratories UK [...]

The post MHRA Class 4 Medicines Notification Various Products (Ipca Laboratories UK Limited) appeared first on Community Pharmacy England.

To receive vaccines ahead of the start of the new Childhood Flu Vaccination Service on 1st October 2025, pharmacy owners will need to register to provide the service on the MYS portal by 11.59pm on 31st August 2025. Later registration will be possible, but the provision of the centrally procured vaccine will be received after [...]

The post Childhood flu: Deadline approaching for receiving vaccines ahead of the start date appeared first on Community Pharmacy England.

Eli Lilly has announced plans to increase the NHS list prices of all strengths of Tirzepatide (Mounjaro®) from 1st September 2025, which will impact on the dispensing of NHS prescriptions by community pharmacies. Community Pharmacy England is urgently seeking assurances from the Department of Health and Social Care (DHSC) that reimbursement of NHS prescriptions (branded [...]

The post Tirzepatide (Mounjaro®) pricing: Information for pharmacy owners appeared first on Community Pharmacy England.